In recent weeks the online alternative medicine and independent news communities have been exploring a pattern of troubling deaths and disappearances of physicians in the United States. This pattern of murders and suspicious deaths and disappearances has led one journalist with contacts in the alternative medicine community to allege that the events are related to an aggressive effort to suppress findings about a protein present in vaccines that can foster immune system dysfunction that leads to autism, as well as a natural immune system compound that can be used to help reverse the damage and heal autism and other conditions, including cancer.
This topic centers around the work of Jeffrey Bradstreet, M.D. Dr. Bradstreet was a physician trained at the University of South Florida and a veteran doctor who had practiced in Florida for many years before moving to Georgia. Bradstreet’s own son was autistic and he had devoted many years to exploring novel treatment approaches for autism. He was found washed up by a river dead in June 2015 in North Carolina, with a gunshot wound that authorities claimed was self-inflicted. Dr. Bradstreet’s office had been recently visited by investigators from the FDA, and the journalist alleging foul play claims to have been told that the FDA was investigating his use of GcMAF to treat autism, in violation of FDA prohibitions of the use of this compound. The findings about the effectiveness of GcMAF had been published by Dr. Bradstreet and presented at the AutismOne Conference in Miami in March 2014. Bradstreet was recognized around the world for his cutting edge research on autism therapies, with his knowledge about treatments ranging from GcMAF to cannabadiol (CBD), stem cell therapy, and magnetic resonant therapy.
This series of recent sudden deaths includes an acclaimed alternative cancer doctor, Nicholas Gonzalez, who died of apparent cardiac arrest and had also researched the use of GcMAF for helping the immune system reverse cancers. It also follows a controversial court case involving the FDA’s prosecution of a man named Daniel Smith for his distribution and promotion of a compound known as MMS or CD (sodium chlorite activated with citric acid or another acid compound to produce chlorine dioxide). Smith was recently convicted and sentenced to a prison term for his selling this compound as a health aid for human consumption after the FDA had issued a warning about its use and taken action to suppress the distribution of the simple, inexpensive chemical solution.
Sodium chlorite and chlorine dioxide have been used for many years as water purification chemicals and food sanitization chemicals precisely because they work to quickly neutralize any microbes that might contaminate water or food. Used with appropriate cautions and proper concentrations chlorine dioxide has been found by many users to seemingly “cure” ailments they have, ranging from acute infectious conditions to conditions such as HIV, cancer, and autism. Since immune system suppression or corruption and unchecked infections appear to play a role in all of those conditions, it would seem logical that chlorine dioxide could be an effective therapy. Chemist Jim Humble, who stumbled upon the seemingly miraculous properties of chlorine dioxide when applying it to wipe out malaria infections in Africa, has been researching it and collecting testimonials from thousands of people who report having benefited from it.
Thus, the FDA has visibly taken actions to suppress two seemingly highly promising alternative medicines used in protocols to reverse autism. On the heels of those legal actions, several physicians, including at least a couple who are publicly associated with the use of one of those suppressed treatments, have turned up dead.
According to a European website on GcMAF treatment, Dr. Jeffrey Bradstreet had treated over 2,000 autistic children with GcMAF and the results are well established. In 15% GcMAF makes no difference. 85% improve, if only a little, and of them 15% have their autism eradicated. In all 3,000 children have been treated with GcMAF with similar results. Dr. Bradstreet had published a paper: “Initial Observations of Elevated Alpha-N-Acetylgalactosaminidase Activity Associated with Autism and Observed Reductions from GC Protein—Macrophage Activating Factor Injections“ which was considered ground breaking in its discoveries.
Those observing the research and publishing the information report that “In our opinion Autism tends to be caused by the MMR and other vaccines putting viruses and mercury into children. A shortage of lipids may contribute. Another Italian court has awarded €178,000 against the government to a family whose child contracted autism from MMR. These viruses sabotage the immune system by sending out nagalase to prevent the production of the child’s GcMAF, and therefore become chronic. Autism is usually a viral disease to a greater or lesser extent, with viruses in the brain and the stomach. In 15% of children viruses are negligible, and GcMAF probably will not help. In 85% viruses are involved, and they will respond to GcMAF. In 15% of children autism is mainly a viral disease, and these children make full recoveries.”
Dr. N. Yamamoto discovered the Macrophage Activating Factor (GcMAF) in 1990 at the Socrates Institute in Philadelphia. Since that time, Dr. Yamamoto has published three human clinical trials yielding impressive results for breast, colo-rectal, and prostate cancer. MAF is a protein which activates our macrophages, the microscopic white cells that kill invading microbes and cancer cells. MAF is made from a precursor protein called the Gc protein. Cancer cells are clever at disabling our immune system in order to enhance their own survival. Dr. Yamamoto discovered that cancer cells do this by secreting an enzyme called Nagalase, which prevents the precursor protein Gc from being converted to MAF. This Nagalase enzyme activity can actually be measured in cancer patients, and greater tumor burden corresponds with higher Nagalase enzyme activity. Elimination of the tumor results in reduction of Nagalase activity to lower, more normal values. Dr. Yamamoto devised a technique for restoring Gc protein activity which creates the most potent macrophage activating factor ever discovered, having no apparent adverse effects. He called it GcMAF. Macrophages treated in vitro with GcMAF (100 pg/ml) are highly effective at killing breast cancer cells.
If Nagalase enzymes are introduced to the body in vaccines, then vaccines could also trigger immune suppression and create conditions that might respond to GcMAF therapy. Like cancer cells, virus particles (which are present in vaccines) also make Nagalase. Their goal is the same as that of the cancer cells: survival by incapacitating their number one enemy, the immune system. It would be valuable for more research to be done in this area. Unfortunately, the FDA has actively blocked doctors from using this treatment and at least a couple of this therapy’s most prominent proponents in the USA are now dead.
CLICK THE IMAGE BELOW TO LEARN MORE